drug-induced dyskinesia
These changes are compatible with a Ca2+-induced potentiation of dopamine receptor signaling which may contribute to the drug-induced dyskinesia in RGS9-deficient mice.
These changes are compatible with a Ca2+-induced potentiation of dopamine receptor signaling which may contribute to the <span class="disease" id="24663062-12-121-144">drug-induced dyskinesia</span> in <span class="gene" id="24663062-12-148-152">RGS9</span>-deficient mice.